Results 221 to 230 of about 4,409,486 (250)

The Circular Economy—A New Resilience Paradigm?

Business Strategy and the Environment, EarlyView.
ABSTRACT The circular economy (CE) has traditionally been positioned as a central instrument of the sustainability paradigm. Yet escalating geopolitical volatility and supply chain fragility have elevated resilience to a parallel strategic imperative, and the conceptual integration of CE and resilience remains underexplored.
Julian Kirchherr, Felix Carl Schultz
wiley   +1 more source

Editorial: Safety consideration in the development of anti-tumor monoclonal antibodies during drug development. [PDF]

Front Oncol
Wang T, Abedin SE, van der Laan JW.
europepmc   +1 more source

Elucidating the Interplay Between Structure and Electrochemical Behavior in Lignin‐Based Polymer Electrolytes for Potassium Batteries

Battery Energy, Volume 4, Issue 2, March 2025.
Three biobased membranes are synthesized by crosslinking oxidized Kraft lignin with poly(ethylene glycol) diglycidyl ether of increasing molecular weights. After incorporation of solvated potassium salts, potassium batteries including these biobased gel polymer electrolytes are able to deliver a maximum specific capacity at 0.05 A g−1 as high as 130 ...
Giuseppe Pascuzzi, Sabrina Trano, Carlotta Francia, Stefano Turri, Federico Bella, Gianmarco Griffini   +5 more
wiley   +1 more source

Engineered macrophages accumulate in solid tumors and locally deliver immune-activating proteins to inhibit tumor progression. [PDF]

Transl Cancer Res
Xu Y, Zhou Y, Wang J.
europepmc   +1 more source

Screening of bispecific antibodies during single cell cloning of recombinant Chinese hamster ovary cell lines to improve titer and product quality

Biotechnology Progress, EarlyView.
Abstract Development of therapeutic bispecific antibodies (BsAbs) poses significant manufacturability challenges associated with correct chain pairing and an increased diversity of impurities. Here we address this with a product quality assessment during cell line development (CLD), forgoing the need for genetic characterization during cell line ...
Molly Robinson, Jessica Willmott, Holly Corrigall, Daniela Lega, Joseph Stirling, Vithiya Vimalraj, Mitul Patel, Robyn Emmins   +7 more
wiley   +1 more source

HDX-MS-Guided computational modeling for rapid and accurate antibody-antigen interface mapping. [PDF]

MAbs
McMahon W, Zhang H, Li X, Oganesyan V, Payne S, Mehzabeen N, Dyk NV, Liu W, Howard W, Zhao P, Zhang Y, Fang M, Chen X, Mazor Y, Shi Y.   +14 more
europepmc   +1 more source

Successful treatment of anti-LGI1-associated autoimmune encephalitis with efgartigimod: A case report and literature review. [PDF]

Medicine (Baltimore)
Gao R, Hong Y, Zhou G.
europepmc   +1 more source

Brain Delivery of Antibody-Derived Biologicals for Alzheimer's Disease: An Updated Narrative Review. [PDF]

Antibodies (Basel)
Sumbria RK, Boado RJ.
europepmc   +1 more source

Pharmacodynamics and Pharmacokinetics of Ublituximab Compared with Other Anti-CD20 Monoclonal Antibodies for Multiple Sclerosis Treatment. [PDF]

Curr Neuropharmacol
Margoni M, Battistini L, Centonze D, Furlan R, Gasperini C, Filippi M.   +5 more
europepmc   +1 more source

Carriers Multimerize STING Protein Fragments to Activate Type I Interferon Signaling in STING-Deficient Cancer Cells. [PDF]

Mol Pharm
Kaskow JA, Hammond PT.
europepmc   +1 more source